GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Shineway Pharmaceutical Group Ltd (HKSE:02877) » Definitions » Tax Expense

China Shineway Pharmaceutical Group (HKSE:02877) Tax Expense : HK$353 Mil (TTM As of Jun. 2024)


View and export this data going back to 2004. Start your Free Trial

What is China Shineway Pharmaceutical Group Tax Expense?

China Shineway Pharmaceutical Group's tax expense for the months ended in Jun. 2024 was HK$254 Mil. Its tax expense for the trailing twelve months (TTM) ended in Jun. 2024 was HK$353 Mil.


China Shineway Pharmaceutical Group Tax Expense Historical Data

The historical data trend for China Shineway Pharmaceutical Group's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Shineway Pharmaceutical Group Tax Expense Chart

China Shineway Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Tax Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 155.36 118.53 200.11 216.92 296.13

China Shineway Pharmaceutical Group Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 94.11 127.27 196.69 99.45 253.64

China Shineway Pharmaceutical Group Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$353 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Shineway Pharmaceutical Group  (HKSE:02877) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


China Shineway Pharmaceutical Group Tax Expense Related Terms

Thank you for viewing the detailed overview of China Shineway Pharmaceutical Group's Tax Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


China Shineway Pharmaceutical Group Business Description

Traded in Other Exchanges
Address
Luan Cheng, Hebei Province, Shijiazhuang, CHN
China Shineway Pharmaceutical Group Ltd is an investment holding company in the People's Republic of China. It is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, and others of which injection generates maximum revenue to the company.
Executives
Bh Corporate Services Ltd 2301 Trustee
Bodnar-horvath Kwai Yung Helen 2202 Interest of your spouse
Bodnar-horvath Nicholas Eugene Francis 2201 Interest of corporation controlled by you
Forway Investment Limited 2101 Beneficial owner
Li Zhenjiang 2307 Founder of a discretionary trust who can infl

China Shineway Pharmaceutical Group Headlines

No Headlines